BMJ Best Practice

参考文献

关键文献

Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention - United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57:1-28.

World Health Organization. Weekly epidemiological record. Rabies vaccines: WHO position paper. April 2018 [internet publication].

World Health Organization. WHO expert consultation on rabies: WHO TRS N°1012 (third report). April 2018 [internet publication].

Rupprecht CE, Briggs D, Brown CM, et al; Centers for Disease Control and Prevention. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2010;59:1-9.

Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508-2514.

参考文章

1.  World Health Organization. Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030. June 2018 [internet publication].

2.  Rawat AK, Rao SK. Survival of a rabies patient. Indian Pediatr. 2011;48:574.

3.  Centers for Disease Control and Prevention. Presumptive abortive human rabies - Texas, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:185-190.

4.  Karahocagil MK, Akdeniz H, Aylan O, et al. Complete recovery from clinical rabies: case report. Turkiye Klinikleri J Med Sci. 2013;33:547-552.

5.  Hampson K, Coudeville L, Lembo T, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9:e0003709.

6.  Rupprecht CE, Gibbons RV. Clinical practice: prophylaxis against rabies. N Engl J Med. 2004;351:2626-2635.

7.  Centers for Disease Control and Prevention. Human rabies. August 2017 [internet publication].

8.  Pieracci EG, Pearson CM, Wallace RM, et al. Vital signs: trends in human rabies deaths and exposures - United States, 1938-2018. MMWR Morb Mortal Wkly Rep. 2019 Jun 14;68(23):524-8.

9.  Pan American Health Organisation. Rabies persists in only four countries of Latin America and the Caribbean. 21 September 2018 [internet publication].

10.  Rotivel Y, Goudal M, Wirth S, et al. Rabies is a risk for travelling children [in French]. Arch Pediatr. 1998;5:561-567.

11.  Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med. 1998;128:922-930.

12.  Blanton JD, Palmer D, Dyer J, et al. Rabies surveillance in the United States during 2010. J Am Vet Med Assoc. 2011;239:773-783.

13.  Messenger SL, Smith JS, Rupprecht CE. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin Infect Dis. 2002;35:738-747.

14.  Public Health England. Public Health England warns travellers of rabies risk. 12 November 2018 [internet publication].

15.  Velasco-Villa A, Reeder SA, Orciari LA, et al. Enzootic rabies elimination from dogs and reemergence in wild terrestrial carnivores, United States. Emerg Infect Dis. 2008;14:1849-1854.

16.  Kuzmin IV, Mayer AE, Niezgoda M, et al. Shimoni bat virus, a new representative of the Lyssavirus genus. Virus Res. 2010;149:197-210.

17.  Marston DA, Horton DL, Ngeleja C, et al. Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet. Emerg Infect Dis. 2012;18:664-667.

18.  Picard-Meyer E, Servat A, Robardet E, et al. Isolation of Bokeloh bat lyssavirus in Myotis nattereri in France. Arch Virol. 2013;158:2333-2340.

19.  Vora NM, Basavaraju SV, Feldman KA, et al; Transplant-Associated Rabies Virus Transmission Investigation Team. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA. 2013;310:398-407.

20.  Monroe BP, Yager P, Blanton J, et al. Rabies surveillance in the United States during 2014. J Am Vet Med Assoc. 2016;248:777-788.

21.  Zhou H, Zhu W, Zeng J, et al. Probable rabies virus transmission through organ transplantation, China, 2015. Emerg Infect Dis. 2016;22:1348-1352.

22.  Saeed B, Al-Mousawi M. Rabies acquired through kidney transplantation in a child: a case report. Exp Clin Transplant. 2017;15:355-357.

23.  Lafon M. Rabies virus receptors. J Neurovirol. 2005;11:82-87.

24.  Jackson AC. Diabolical effects of rabies encephalitis. J Neurovirol. 2016;22:8-13.

25.  Rossiter JP, Hsu L, Jackson AC. Selective vulnerability of dorsal root ganglia neurons in experimental rabies after peripheral inoculation of CVS-11 in adult mice. Acta Neuropathol. 2009;118:249-259.

26.  Hemachudha T, Wacharapluesadee S, Mitrabhakdi E, et al. Pathophysiology of human paralytic rabies. J Neurovirol. 2005;11:93-100.

27.  Hemachudha T, Ugolini G, Wacharapluesadee S, et al. Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neurol. 2013;12:498-513.

28.  Gibbons RV. Cryptogenic rabies, bats, and the question of aerosol transmission. Ann Emerg Med. 2002;39:528-536.

29.  Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention - United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57:1-28.

30.  World Health Organization. Weekly epidemiological record. Rabies vaccines: WHO position paper. April 2018 [internet publication].

31.  Kessels JA, Recuenco S, Navarro-Vela AM, et al. Pre-exposure rabies prophylaxis: a systematic review. Bull World Health Organ. 2017;95:210C-219C.

32.  Anderson LJ, Nicholson KG, Tauxe RV, et al. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann Intern Med. 1984;100:728-735.

33.  Soun VV, Eidson M, Trimarchi CV, et al. Antemortem diagnosis of New York human rabies case and review of U.S. cases. Int J Biomed Sci. 2006;2:433-444.

34.  Hemachudha T, Laothmatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet. 2002;2:101-109.

35.  World Health Organization. WHO expert consultation on rabies: WHO TRS N°1012 (third report). April 2018 [internet publication].

36.  Laothamatas J, Hemachudha T, Mitrabhakdi E, et al. MR imaging in human rabies. AJNR Am J Neuroradiol. 2003;24:1102-1109.

37.  Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54:899-904.

38.  Hantson P, Guerit JM, de Tourtchaninoff M, et al. Rabies encephalitis mimicking the electrophysiological pattern of brain death. Eur Neurol. 1993;33:212-217.

39.  Centers for Disease Control and Prevention. Rabies, human: 2011 case definition. 2011 [internet publication].

40.  Rupprecht CE, Briggs D, Brown CM, et al; Centers for Disease Control and Prevention. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2010;59:1-9.

41.  Public Health England. Guidelines on managing rablies post-exposure. April 2019 [internet publication].

42.  Willoughby RE Jr, Opladen T, Maier T, et al. Tetrahydrobiopterin deficiency in human rabies. J Inherit Metab Dis. 2008;32:65-68.

43.  Marsden SC, Cabanban CR. Rabies: a significant palliative care issue. Prog Palliat Care. 2006;14:62-67.

44.  Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis. 2003;36:60-63.

45.  Medical College of Wisconsin. Milwaukee rabies protocol, version 5.2. April 2017 [internet publication].

46.  Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508-2514.

47.  Willoughby RE, Roy-Burman A, Martin KW, et al. Generalized cranial artery spasm in human rabies. Dev Biol (Basel). 2008;131:367-375.

48.  World Health Organization. Rabies monoclonal antibodies post exposure prophylaxis. December 2016 [internet publication].

49.  Gogtay NJ, Munshi R, Ashwath Narayana DH, et al. Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2/3, randomized, single-blind, noninferiority, controlled study. Clin Infect Dis. 2018 Jan 18;66(3):387-395.

50.  Yamada K, Noguchi K, Komeno T, et al. Efficacy of favipiravir (T-705) in rabies postexposure prophylaxis. J Infect Dis. 2016;213:1253-1261.

51.  Bussereau F, Picard M, Blancou J, et al. Treatment of rabies in mice and foxes with antiviral compounds. Acta Virol. 1988;32:33-49.

52.  Kalimuddin S, Wijaya L, Chan YFZ, et al. A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen. Vaccine. 2017 Nov 22;35(51):7127-32.

53.  Mani RS, Anand AM, Madhusudana SN. Human rabies in India: an audit from a rabies diagnostic laboratory. Trop Med Int Health. 2016 Apr;21(4):556-63.

使用此内容应接受我们的免责声明